glp 1 inhibitors mechanism of action Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Mechanism of action of GLP-1
Description
"These results suggest that when GLP-1 receptor agonists are clinically indicated for cardiometabolic reasons, potential benefits for substance-related outcomes may be an added consideration in shared decision-making."

It deserves its own science rather than being treated as a simple extension of midlife obesity, she says

Whether you are starting GLP-1 therapy for the first time or considering a switch between medications, understanding the key differences will help you make an informed decision with your healthcare provider
In addition, the insulinotropic effect of the dual GIP/GLP-1 receptor agonist was abrogated by GIP receptor antagonist (GIPRA) in GLP-1R null mice (63)

Regarding this, GLP-1RAs inhibit ER stress and promote protein folding via endoplasmic reticulum oxidoreductase (ERO1) in an AMPK-dependent manner, as well as mediating the process of mitochondrial fusion [115, 151]

R.et al (2015)
